Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02559063 · ClinicalTrials.gov registry record · NA

Vision-based Speed of Processing Cognitive Training and Mild Cognitive Impairment

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT02559063: Completed NA study, sponsored by University of Rochester.

NCT02559063 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02559063, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

This project seeks to identify neural changes that occur in adults with mild cognitive impairment (MCI) after engagement in computerized cognitive training. In addition, this project aims to identify physiological factors that may bolster effects of the training on cognitive function. Individuals with MCI are at high risk for Alzheimer's disease (AD). Understanding how cognitive training protects cognitive function in MCI can contribute to development of effective interventions to slow progression to AD in individuals at risk, thereby reducing the significant morbidity and health care costs associated with AD.

Interventions

  • BEHAVIORAL Vision-based speed of processing training
  • BEHAVIORAL Mental leisure activities

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2016-01-12
Est. Completion 2019-07-01
Phase NA
University of Rochester

636 total trials

What the finished NCT02559063 record still lists

NCT02559063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Vision-based speed of processing training is the first listed.

NCT02559063 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02559063 about?

NCT02559063 is a clinical study titled "Vision-based Speed of Processing Cognitive Training and Mild Cognitive Impairment". This project seeks to identify neural changes that occur in adults with mild cognitive impairment (MCI) after engagement in computerized cognitive training. In addition, this project aims to identify physiological factors that may bolster effects of the training on cognitive function. Individuals wi...

What is the current status of trial NCT02559063?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2016-01-12. Estimated completion is 2019-07-01.

What interventions are being tested in trial NCT02559063?

The interventions under investigation include: Vision-based speed of processing training (BEHAVIORAL), Mental leisure activities (BEHAVIORAL).

Who is sponsoring clinical trial NCT02559063?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02559063's enrollment target sits among peer trials

84 983rd of 2000 higher than 1,011 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02559063, the US trial registry maintained by the National Library of Medicine. NCT02559063 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.